Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

Eitemau Tebyg

• Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.
  gan: Ulmert, D, et al.
  Cyhoeddwyd: (2008)
• Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study
  gan: Berglund Göran, et al.
  Cyhoeddwyd: (2008-02-01)
• Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.
  gan: Lilja, H, et al.
  Cyhoeddwyd: (2011)
• Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
  gan: Ulmert, D, et al.
  Cyhoeddwyd: (2008)
• Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
  gan: Lilja, H, et al.
  Cyhoeddwyd: (2008)